Skip to main content
Have a personal or library account? Click to login
Effects of lactoferrin and progesterone on the endometriotic lesion in a female rat model Cover

Effects of lactoferrin and progesterone on the endometriotic lesion in a female rat model

Open Access
|Jun 2026

Abstract

Background

Lactoferrin (LF), a multifunctional glycoprotein of the transferrin family, exhibits anti-inflammatory and immunomodulatory properties. Endometriosis is an estrogen-dependent chronic inflammatory disease commonly treated with progesterone therapy; however, progesterone receptor (PGR) resistance in endometriotic lesions has increased interest in immunomodulatory approaches.

Objective

To evaluate the effects of LF alone and combined with progesterone on endometriotic lesions in a rat model.

Methods

An endometriosis model was induced in female Wistar Albino rats. Rats with confirmed endometriotic lesions were randomly divided into 4 equal groups and received the following oral treatments: Control (0.5% carboxymethylcellulose), bovine LF (bLF) (100 mg/kg/d), progesterone (0.3 mg/kg/day), combination therapy (bLF [100 mg/kg/d] + progesterone [0.3 mg/kg/d]). After treatment, the rats were euthanized, histopathological and biochemically anayses were done.

Results

No statistically significant differences were observed in volume and adhesion scores of endometriotic lesions before and after treatment (P = 0.653, P = 0.413, P = 0.890, respectively). However, PGR and inflammatory cytocine levels were decreased in all treatment groups (P = 0.001). Although serum progesterone levels did not differ between groups (P = 0.06), serum LF levels were lower in the progesterone-only group (P = 0.001). Total antioxidant status (TAS) and Plasma total oxidant status (TOS) showed no significant differences among groups (P = 0.623 and P = 0.318, respectively).

Conclusion

LF, alone or combined with progesterone, reduced inflammatory cytokine levels associated with endometriosis-related pain, suggesting potential therapeutic value. Further studies are needed to clarify its role in progesterone resistance and the clinical management of endometriosis.

DOI: https://doi.org/10.2478/abm-2026-0019 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 161 - 169
Published on: Jun 30, 2026
In partnership with: Paradigm Publishing Services

© 2026 İrem Şenyuva, Duygu Baki Acar, Hasan Hüseyin Demirel Bayat, Funda Karabağ, Ece Tunç, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution 4.0 License.